Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 12, 2024 Filed Dec 13, 2024 16:15 UTC |
Bruno Anthony DDirector
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $2.40 | $0.00 |
DisclosureSEC source: 0001415889-24-029286 · form4-12132024_041207.xml · derivative · entry 1 Bruno Anthony D · CIK 0001374180 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2034-12-11 F1 · derivative.exercise_date: Represents the annual award to non-employee directors of the Issuer, awarded on the date of the Issuer's annual meeting of stockholders. The shares subject to the option vest on December 12, 2025, subject to the Reporting Person's continuous service through such date. Read SEC document |
| December 12, 2024 Filed Dec 13, 2024 16:15 UTC |
BARBARI SHARONDirector
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $2.40 | $0.00 |
DisclosureSEC source: 0001415889-24-029289 · form4-12132024_041213.xml · derivative · entry 1 BARBARI SHARON · CIK 0001240499 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2034-12-11 F1 · derivative.exercise_date: Represents the annual award to non-employee directors of the Issuer, awarded on the date of the Issuer's annual meeting of stockholders. The shares subject to the option vest on December 12, 2025, subject to the Reporting Person's continuous service through such date. Read SEC document |
| December 12, 2024 Filed Dec 13, 2024 21:15 UTC |
Borowski ChristineDirector
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $2.40 | $0.00 |
DisclosureSEC source: 0001415889-24-029291 · form4-12132024_041217.xml · derivative · entry 1 Borowski Christine · CIK 0002005073 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2034-12-11 F1 · derivative.exercise_date: Represents the annual award to non-employee directors of the Issuer, awarded on the date of the Issuer's annual meeting of stockholders. The shares subject to the option vest on December 12, 2025, subject to the Reporting Person's continuous service through such date. Read SEC document |
| December 12, 2024 Filed Dec 13, 2024 21:15 UTC |
Little Elisabeth SandovalDirector
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $2.40 | $0.00 |
DisclosureSEC source: 0001415889-24-029287 · form4-12132024_041209.xml · derivative · entry 1 Sandoval Elisabeth · CIK 0001632295 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2034-12-11 F1 · derivative.exercise_date: Represents the annual award to non-employee directors of the Issuer, awarded on the date of the Issuer's annual meeting of stockholders. The shares subject to the option vest on December 12, 2025, subject to the Reporting Person's continuous service through such date. Read SEC document |
| November 30, 2024 Filed Dec 3, 2024 21:15 UTC |
Domzalski DavidDirector · PRESIDENT AND CEO
|
GrantCommon Stock | 3,901 | $2.10 | $8,192.10 |
DisclosureSEC source: 0001415889-24-028073 · form4-12032024_041201.xml · nonDerivative · entry 1 Domzalski David · CIK 0001727794 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 500,597 F1 · kind: These shares were acquired under the Issuer's Employee Share Purchase Plan ("ESPP") for the ESPP purchase period beginning on June 1, 2024 and ending on November 30, 2024 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the fair market value closing price of the Issuer's common stock on June 3, 2024 (the first trading day of the offering period). The Reporting Person purchased the maximum number of shares permitted by the terms of the ESPP during the calendar year. Read SEC document |
| September 30, 2024 Filed Oct 2, 2024 20:15 UTC |
Zeronda TylerCHIEF FINANCIAL OFFICER
|
Tax withholdingCommon Stock | 84 | $1.88 | $157.92 |
DisclosureSEC source: 0001415889-24-024383 · form4-10022024_041008.xml · nonDerivative · entry 1 Zeronda Tyler · CIK 0001867033 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 131,567 F1 · shares: Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| September 30, 2024 Filed Oct 2, 2024 20:15 UTC |
Stuart IainCHIEF SCIENTIFIC OFFICER
|
Tax withholdingCommon Stock | 109 | $1.88 | $204.92 |
DisclosureSEC source: 0001415889-24-024382 · form4-10022024_041005.xml · nonDerivative · entry 1 Stuart Iain · CIK 0001727756 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 133,494 F1 · shares: Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| September 30, 2024 Filed Oct 2, 2024 20:15 UTC |
Domzalski DavidDirector · PRESIDENT AND CEO
|
Tax withholdingCommon Stock | 685 | $1.88 | $1,287.80 |
DisclosureSEC source: 0001415889-24-024380 · form4-10022024_041001.xml · nonDerivative · entry 1 Domzalski David · CIK 0001727794 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 496,696 F1 · shares: Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| September 30, 2024 Filed Oct 2, 2024 20:15 UTC |
Harsch MutyaCHIEF LEGAL OFFICER AND GC
|
Tax withholdingCommon Stock | 105 | $1.88 | $197.40 |
DisclosureSEC source: 0001415889-24-024381 · form4-10022024_041004.xml · nonDerivative · entry 1 Harsch Mutya · CIK 0001727809 · CHIEF LEGAL OFFICER AND GC 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 149,026 F1 · shares: Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| July 01, 2024 Filed Jul 3, 2024 20:15 UTC |
Zeronda TylerCHIEF FINANCIAL OFFICER
|
Tax withholdingCommon Stock | 92 | $1.92 | $176.64 |
DisclosureSEC source: 0001415889-24-019176 · form4-07032024_040715.xml · nonDerivative · entry 1 Zeronda Tyler · CIK 0001867033 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 131,651 F1 · shares: Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| July 01, 2024 Filed Jul 3, 2024 20:15 UTC |
Stuart IainCHIEF SCIENTIFIC OFFICER
|
Tax withholdingCommon Stock | 138 | $1.92 | $264.96 |
DisclosureSEC source: 0001415889-24-019175 · form4-07032024_040713.xml · nonDerivative · entry 1 Stuart Iain · CIK 0001727756 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 133,603 F1 · shares: Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| July 01, 2024 Filed Jul 3, 2024 20:15 UTC |
Harsch MutyaCHIEF LEGAL OFFICER AND GC
|
Tax withholdingCommon Stock | 143 | $1.92 | $274.56 |
DisclosureSEC source: 0001415889-24-019174 · form4-07032024_040711.xml · nonDerivative · entry 1 Harsch Mutya · CIK 0001727809 · CHIEF LEGAL OFFICER AND GC 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 149,131 F1 · shares: Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| July 01, 2024 Filed Jul 3, 2024 20:15 UTC |
Domzalski DavidDirector · PRESIDENT AND CEO
|
Tax withholdingCommon Stock | 935 | $1.92 | $1,795.20 |
DisclosureSEC source: 0001415889-24-019173 · form4-07032024_040709.xml · nonDerivative · entry 1 Domzalski David · CIK 0001727794 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 497,654 F1 · shares: Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 20:30 UTC |
Domzalski DavidDirector · PRESIDENT AND CEO
|
GrantCommon Stock | 4,429 | $2.16 | $9,562.21 |
DisclosureSEC source: 0001415889-24-015370 · form4-06042024_040620.xml · nonDerivative · entry 1 Domzalski David · CIK 0001727794 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 498,589 F1 · shares: These shares were acquired under the Issuer's Employee Share Purchase Plan ("ESPP") for the ESPP purchase period beginning on December 1, 2023 and ending on May 31, 2024 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the fair market value closing price of the Issuer's common stock on May 31, 2024. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 21:08 UTC |
Zeronda TylerCHIEF FINANCIAL OFFICER
|
Tax withholdingCommon Stock | 94 | $3.08 | $289.52 |
DisclosureSEC source: 0001415889-24-010074 · form4-04032024_090450.xml · nonDerivative · entry 1 Zeronda Tyler · CIK 0001867033 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 131,743 F1 · shares: Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 21:06 UTC |
Stuart IainCHIEF SCIENTIFIC OFFICER
|
Tax withholdingCommon Stock | 157 | $3.08 | $483.56 |
DisclosureSEC source: 0001415889-24-010070 · form4-04032024_090410.xml · nonDerivative · entry 1 Stuart Iain · CIK 0001727756 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 133,741 F1 · shares: Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 21:04 UTC |
Harsch MutyaCHIEF LEGAL OFFICER AND GC
|
Tax withholdingCommon Stock | 161 | $3.08 | $495.88 |
DisclosureSEC source: 0001415889-24-010067 · form4-04032024_090429.xml · nonDerivative · entry 1 Harsch Mutya · CIK 0001727809 · CHIEF LEGAL OFFICER AND GC 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 149,274 F1 · shares: Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 21:02 UTC |
Domzalski DavidDirector · PRESIDENT AND CEO
|
Tax withholdingCommon Stock | 1,004 | $3.08 | $3,092.32 |
DisclosureSEC source: 0001415889-24-010064 · form4-04032024_090445.xml · nonDerivative · entry 1 Domzalski David · CIK 0001727794 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 494,160 F1 · shares: Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| January 02, 2024 Filed Jan 3, 2024 22:22 UTC |
Zeronda TylerChief Financial Officer
|
Tax withholdingCommon Stock | 93 | $2.28 | $212.04 |
DisclosureSEC source: 0001209191-24-000470 · doc4.xml · nonDerivative · entry 2 Zeronda Tyler · CIK 0001867033 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 131,837 F3 · shares: Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| January 02, 2024 Filed Jan 3, 2024 22:21 UTC |
Stuart IainChief Scientific Officer
|
Tax withholdingCommon Stock | 157 | $2.28 | $357.96 |
DisclosureSEC source: 0001209191-24-000469 · doc4.xml · nonDerivative · entry 2 Stuart Iain · CIK 0001727756 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 133,898 F3 · shares: Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| January 02, 2024 Filed Jan 3, 2024 22:20 UTC |
Harsch MutyaChief Legal Officer and GC
|
Tax withholdingCommon Stock | 161 | $2.28 | $367.08 |
DisclosureSEC source: 0001209191-24-000467 · doc4.xml · nonDerivative · entry 2 Harsch Mutya · CIK 0001727809 · Chief Legal Officer and GC 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 149,435 F3 · shares: Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| January 02, 2024 Filed Jan 3, 2024 22:17 UTC |
Domzalski DavidDirector · President and CEO
|
Tax withholdingCommon Stock | 1,004 | $2.28 | $2,289.12 |
DisclosureSEC source: 0001209191-24-000465 · doc4.xml · nonDerivative · entry 2 Domzalski David · CIK 0001727794 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 495,164 F3 · shares: Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| January 01, 2024 Filed Jan 3, 2024 17:13 UTC |
LEPORE PATRICK GDirector
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $2.33 | $0.00 |
DisclosureSEC source: 0001209191-24-000462 · doc4.xml · derivative · entry 1 LEPORE PATRICK G · CIK 0001055404 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2033-12-31 F1 · derivative.exercise_date: The shares subject to the option vest on January 1, 2025, subject to the Reporting Person's continuous service through such date. Read SEC document |
| January 01, 2024 Filed Jan 3, 2024 17:10 UTC |
Basta Steven LDirector
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $2.33 | $0.00 |
DisclosureSEC source: 0001209191-24-000460 · doc4.xml · derivative · entry 1 Basta Steven L · CIK 0001417397 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2033-12-31 F1 · derivative.exercise_date: The shares subject to the option vest on January 1, 2025, subject to the Reporting Person's continuous service through such date. Read SEC document |
| January 01, 2024 Filed Jan 3, 2024 17:11 UTC |
Bruno Anthony DDirector
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $2.33 | $0.00 |
DisclosureSEC source: 0001209191-24-000461 · doc4.xml · derivative · entry 1 Bruno Anthony D · CIK 0001374180 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2033-12-31 F1 · derivative.exercise_date: The shares subject to the option vest on January 1, 2025, subject to the Reporting Person's continuous service through such date. Read SEC document |
| January 01, 2024 Filed Jan 3, 2024 17:09 UTC |
BARBARI SHARONDirector
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $2.33 | $0.00 |
DisclosureSEC source: 0001209191-24-000459 · doc4.xml · derivative · entry 1 BARBARI SHARON · CIK 0001240499 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2033-12-31 F1 · derivative.exercise_date: The shares subject to the option vest on January 1, 2025, subject to the Reporting Person's continuous service through such date. Read SEC document |
| January 01, 2024 Filed Jan 3, 2024 22:22 UTC |
Zeronda TylerChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 62,500 | $0.00 Strike: $2.33 | $0.00 |
DisclosureSEC source: 0001209191-24-000470 · doc4.xml · derivative · entry 3 Zeronda Tyler · CIK 0001867033 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,500 Underlying: Common Stock · 62,500 shares Expires 2033-12-31 F4 · derivative.exercise_date: The shares subject to the option vest over a period of 4 years. 25% of the shares subject to the option will vest on March 31, 2025 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date. Read SEC document |
| January 01, 2024 Filed Jan 3, 2024 22:22 UTC |
Zeronda TylerChief Financial Officer
|
GrantCommon Stock | 62,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-000470 · doc4.xml · nonDerivative · entry 1 Zeronda Tyler · CIK 0001867033 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 131,930 F1 · shares: Grant to the Reporting Person of a restricted stock unit ("RSU") award. Each RSU represents a contingent right to receive one share of common stock of the Issuer. F2 · shares: The shares underlying the RSU vest over a period of 4 years. 25% of the shares subject to the award will vest on March 31, 2025 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date. Read SEC document |
| January 01, 2024 Filed Jan 3, 2024 22:21 UTC |
Stuart IainChief Scientific Officer
|
GrantStock Option (right to buy) · Derivative | 62,500 | $0.00 Strike: $2.33 | $0.00 |
DisclosureSEC source: 0001209191-24-000469 · doc4.xml · derivative · entry 3 Stuart Iain · CIK 0001727756 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,500 Underlying: Common Stock · 62,500 shares Expires 2033-12-31 F4 · derivative.exercise_date: The shares subject to the option vest over a period of 4 years. 25% of the shares subject to the option will vest on March 31, 2025 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date. Read SEC document |
| January 01, 2024 Filed Jan 3, 2024 22:21 UTC |
Stuart IainChief Scientific Officer
|
GrantCommon Stock | 62,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-000469 · doc4.xml · nonDerivative · entry 1 Stuart Iain · CIK 0001727756 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 134,055 F1 · shares: Grant to the Reporting Person of a restricted stock unit ("RSU") award. Each RSU represents a contingent right to receive one share of common stock of the Issuer. F2 · shares: The shares underlying the RSU vest over a period of 4 years. 25% of the shares subject to the award will vest on March 31, 2025 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date. Read SEC document |
| January 01, 2024 Filed Jan 3, 2024 22:20 UTC |
Harsch MutyaChief Legal Officer and GC
|
GrantStock Option (right to buy) · Derivative | 62,500 | $0.00 Strike: $2.33 | $0.00 |
DisclosureSEC source: 0001209191-24-000467 · doc4.xml · derivative · entry 3 Harsch Mutya · CIK 0001727809 · Chief Legal Officer and GC 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,500 Underlying: Common Stock · 62,500 shares Expires 2033-12-31 F4 · derivative.exercise_date: The shares subject to the option vest over a period of 4 years. 25% of the shares subject to the option will vest on March 31, 2025 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date. Read SEC document |
| January 01, 2024 Filed Jan 3, 2024 22:20 UTC |
Harsch MutyaChief Legal Officer and GC
|
GrantCommon Stock | 62,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-000467 · doc4.xml · nonDerivative · entry 1 Harsch Mutya · CIK 0001727809 · Chief Legal Officer and GC 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 149,596 F1 · shares: Grant to the Reporting Person of a restricted stock unit ("RSU") award. Each RSU represents a contingent right to receive one share of common stock of the Issuer. F2 · shares: The shares underlying the RSU vest over a period of 4 years. 25% of the shares subject to the award will vest on March 31, 2025 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date. Read SEC document |
| January 01, 2024 Filed Jan 3, 2024 22:17 UTC |
Domzalski DavidDirector · President and CEO
|
GrantStock Option (right to buy) · Derivative | 225,000 | $0.00 Strike: $2.33 | $0.00 |
DisclosureSEC source: 0001209191-24-000465 · doc4.xml · derivative · entry 3 Domzalski David · CIK 0001727794 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 225,000 Underlying: Common Stock · 225,000 shares Expires 2033-12-31 F4 · derivative.exercise_date: The shares subject to the option vest over a period of 4 years. 25% of the shares subject to the option will vest on March 31, 2025 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date. Read SEC document |
| January 01, 2024 Filed Jan 3, 2024 22:17 UTC |
Domzalski DavidDirector · President and CEO
|
GrantCommon Stock | 225,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-000465 · doc4.xml · nonDerivative · entry 1 Domzalski David · CIK 0001727794 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 496,168 F1 · shares: Grant to the Reporting Person of a restricted stock unit ("RSU") award. Each RSU represents a contingent right to receive one share of common stock of the Issuer. F2 · shares: The shares underlying the RSU vest over a period of 4 years. 25% of the shares subject to the award will vest on March 31, 2025 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date. Read SEC document |
| January 01, 2024 Filed Jan 3, 2024 22:14 UTC |
Little Elisabeth SandovalDirector
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $2.33 | $0.00 |
DisclosureSEC source: 0001209191-24-000463 · doc4.xml · derivative · entry 1 Sandoval Elisabeth · CIK 0001632295 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2033-12-31 F1 · derivative.exercise_date: The shares subject to the option vest on January 1, 2025, subject to the Reporting Person's continuous service through such date. Read SEC document |
| January 01, 2024 Filed Jan 3, 2024 22:07 UTC |
Borowski ChristineDirector
|
GrantStock Option (right to buy) · Derivative | 40,000 | $0.00 Strike: $2.33 | $0.00 |
DisclosureSEC source: 0001209191-24-000456 · doc4.xml · derivative · entry 1 Borowski Christine · CIK 0002005073 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2033-12-31 F1 · derivative.exercise_date: The option will vest and become exercisable as to 1/3rd of the shares subject to the option on each annual anniversary of the date of grant, subject to the Reporting Person's continuous service through each applicable vesting date. Read SEC document |
| December 13, 2023 Filed Dec 15, 2023 17:05 UTC |
LEPORE PATRICK GDirector
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $2.70 | $0.00 |
DisclosureSEC source: 0001209191-23-058812 · doc4.xml · derivative · entry 1 LEPORE PATRICK G · CIK 0001055404 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2033-12-12 F1 · derivative.exercise_date: Represents the annual award to non-employee directors of the Issuer, awarded on the date of the Issuer's annual meeting of stockholders. These options vest on December 13, 2024, subject to the Reporting Person's continuous service through such date. Read SEC document |
| December 13, 2023 Filed Dec 15, 2023 17:02 UTC |
Basta Steven LDirector
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $2.70 | $0.00 |
DisclosureSEC source: 0001209191-23-058809 · doc4.xml · derivative · entry 1 Basta Steven L · CIK 0001417397 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2033-12-12 F1 · derivative.exercise_date: Represents the annual award to non-employee directors of the Issuer, awarded on the date of the Issuer's annual meeting of stockholders. These options vest on December 13, 2024, subject to the Reporting Person's continuous service through such date. Read SEC document |
| December 13, 2023 Filed Dec 15, 2023 17:04 UTC |
Bruno Anthony DDirector
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $2.70 | $0.00 |
DisclosureSEC source: 0001209191-23-058811 · doc4.xml · derivative · entry 1 Bruno Anthony D · CIK 0001374180 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2033-12-12 F1 · derivative.exercise_date: Represents the annual award to non-employee directors of the Issuer, awarded on the date of the Issuer's annual meeting of stockholders. These options vest on December 13, 2024, subject to the Reporting Person's continuous service through such date. Read SEC document |
| December 13, 2023 Filed Dec 15, 2023 17:01 UTC |
BARBARI SHARONDirector
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $2.70 | $0.00 |
DisclosureSEC source: 0001209191-23-058807 · doc4.xml · derivative · entry 1 BARBARI SHARON · CIK 0001240499 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2033-12-12 F1 · derivative.exercise_date: Represents the annual award to non-employee directors of the Issuer, awarded on the date of the Issuer's annual meeting of stockholders. These options vest on December 13, 2024, subject to the Reporting Person's continuous service through such date. Read SEC document |
| December 13, 2023 Filed Dec 15, 2023 22:11 UTC |
Zeronda TylerChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 62,500 | $0.00 Strike: $2.70 | $0.00 |
DisclosureSEC source: 0001209191-23-058819 · doc4.xml · derivative · entry 2 Zeronda Tyler · CIK 0001867033 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,500 Underlying: Common Stock · 62,500 shares Expires 2033-12-12 F3 · derivative.exercise_date: The shares subject to the option vest over a period of 4 years. 25% of the shares subject to the option will vest on December 31, 2024 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date. Read SEC document |
| December 13, 2023 Filed Dec 15, 2023 22:11 UTC |
Zeronda TylerChief Financial Officer
|
GrantCommon Stock | 62,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-058819 · doc4.xml · nonDerivative · entry 1 Zeronda Tyler · CIK 0001867033 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,430 F1 · shares: Grant to the Reporting Person of a restricted stock unit ("RSU") award. Each RSU represents a contingent right to receive one share of common stock of the Issuer. F2 · shares: The shares underlying the RSU vest over a period of 4 years. 25% of the shares subject to the award will vest on December 31, 2024 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date. Read SEC document |
| December 13, 2023 Filed Dec 15, 2023 22:10 UTC |
Stuart IainChief Scientific Officer
|
GrantStock Option (right to buy) · Derivative | 62,500 | $0.00 Strike: $2.70 | $0.00 |
DisclosureSEC source: 0001209191-23-058818 · doc4.xml · derivative · entry 2 Stuart Iain · CIK 0001727756 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,500 Underlying: Common Stock · 62,500 shares Expires 2033-12-12 F3 · derivative.exercise_date: The shares subject to the option vest over a period of 4 years. 25% of the shares subject to the option will vest on December 31, 2024 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date. Read SEC document |
| December 13, 2023 Filed Dec 15, 2023 22:10 UTC |
Stuart IainChief Scientific Officer
|
GrantCommon Stock | 62,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-058818 · doc4.xml · nonDerivative · entry 1 Stuart Iain · CIK 0001727756 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,555 F1 · shares: Grant to the Reporting Person of a restricted stock unit ("RSU") award. Each RSU represents a contingent right to receive one share of common stock of the Issuer. F2 · shares: The shares underlying the RSU vest over a period of 4 years. 25% of the shares subject to the award will vest on December 31, 2024 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date. Read SEC document |
| December 13, 2023 Filed Dec 15, 2023 22:09 UTC |
Harsch MutyaChief Legal Officer and GC
|
GrantStock Option (right to buy) · Derivative | 62,500 | $0.00 Strike: $2.70 | $0.00 |
DisclosureSEC source: 0001209191-23-058817 · doc4.xml · derivative · entry 2 Harsch Mutya · CIK 0001727809 · Chief Legal Officer and GC 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,500 Underlying: Common Stock · 62,500 shares Expires 2033-12-12 F3 · derivative.exercise_date: The shares subject to the option vest over a period of 4 years. 25% of the shares subject to the option will vest on December 31, 2024 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date. Read SEC document |
| December 13, 2023 Filed Dec 15, 2023 22:09 UTC |
Harsch MutyaChief Legal Officer and GC
|
GrantCommon Stock | 62,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-058817 · doc4.xml · nonDerivative · entry 1 Harsch Mutya · CIK 0001727809 · Chief Legal Officer and GC 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,096 F1 · shares: Grant to the Reporting Person of a restricted stock unit ("RSU") award. Each RSU represents a contingent right to receive one share of common stock of the Issuer. F2 · shares: The shares underlying the RSU vest over a period of 4 years. 25% of the shares subject to the award will vest on December 31, 2024 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date. Read SEC document |
| December 13, 2023 Filed Dec 15, 2023 22:08 UTC |
Domzalski DavidDirector · President and CEO
|
GrantStock Option (right to buy) · Derivative | 225,000 | $0.00 Strike: $2.70 | $0.00 |
DisclosureSEC source: 0001209191-23-058815 · doc4.xml · derivative · entry 2 Domzalski David · CIK 0001727794 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 225,000 Underlying: Common Stock · 225,000 shares Expires 2033-12-12 F3 · derivative.exercise_date: The shares subject to the option vest over a period of 4 years. 25% of the shares subject to the option will vest on December 31, 2024 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date. Read SEC document |
| December 13, 2023 Filed Dec 15, 2023 22:08 UTC |
Domzalski DavidDirector · President and CEO
|
GrantCommon Stock | 225,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-058815 · doc4.xml · nonDerivative · entry 1 Domzalski David · CIK 0001727794 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 271,168 F1 · shares: Grant to the Reporting Person of a restricted stock unit ("RSU") award. Each RSU represents a contingent right to receive one share of common stock of the Issuer. F2 · shares: The shares underlying the RSU vest over a period of 4 years. 25% of the shares subject to the award will vest on December 31, 2024 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date. Read SEC document |
| December 13, 2023 Filed Dec 15, 2023 22:06 UTC |
Little Elisabeth SandovalDirector
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $2.70 | $0.00 |
DisclosureSEC source: 0001209191-23-058813 · doc4.xml · derivative · entry 1 Sandoval Elisabeth · CIK 0001632295 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2033-12-12 F1 · derivative.exercise_date: Represents the annual award to non-employee directors of the Issuer, awarded on the date of the Issuer's annual meeting of stockholders. These options vest on December 13, 2024, subject to the Reporting Person's continuous service through such date. Read SEC document |
| November 30, 2023 Filed Dec 4, 2023 21:30 UTC |
Domzalski DavidDirector · President and CEO
|
GrantCommon Stock | 2,284 | $2.81 | $6,426.03 |
DisclosureSEC source: 0001209191-23-057220 · doc4.xml · nonDerivative · entry 1 Domzalski David · CIK 0001727794 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,168 F1 · shares: These shares were acquired under the Issuer's Employee Share Purchase Plan ("ESPP") for the ESPP purchase period beginning on June 1, 2023 and ending on November 30, 2023 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the fair market value closing price of the Issuer's common stock on November 30, 2023 (the last trading day of the offering period). The reporting person purchased the maximum number of shares permitted by the terms of the ESPP during the calendar year. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.